1745-7599/asset/JAAN_centre.gif?v=1&s=0091885d2a51bdd0abf3dcd12524a9f0337f1ff4)
Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus
Article first published online: 7 FEB 2008
DOI: 10.1111/j.1745-7599.2007.00290.x
2008 The Author(s) Journal compilation
Issue
Journal of the American Academy of Nurse Practitioners
Volume 20, Issue 2, pages 85–92, February 2008
Additional Information
How to Cite
Farley, J. E. (2008), Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureus. Journal of the American Academy of Nurse Practitioners, 20: 85–92. doi: 10.1111/j.1745-7599.2007.00290.x
Publication History
- Issue published online: 7 FEB 2008
- Article first published online: 7 FEB 2008
- Received: March 2007 accepted: June 2007
- Abstract
- Article
- References
- Cited By
Keywords:
- MRSA;
- community-acquired;
- Staphylococcus aureus
Abstract
Purpose: This article reviews the evolving epidemiology of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) and the appropriate outpatient management of CA-MRSA skin and soft tissue infection. Further, the paper will provide the basis upon which an individualized patient educational plan may be developed.
Data Sources: To complete this review, a search of English language publications was conducted through Medline and CINAHL databases (1966–2006).
Conclusions: The epidemiology of CA-MRSA is becoming increasingly complex. Research that addresses the impact of this organism in high-risk populations and within families is urgently needed.
Implications for Practice: Nurse practitioners must remain informed of the epidemiology of common and emerging drug-resistant organisms in their patient populations.